results of semaglutide for Weight Loss in Orlando TrimRX | Semaglutide Weight Loss

Patients with DM2 have been shown to be at 35 to 60% higher risk of developing atrial fibrillation, which is subsequently associated with a significant risk for all-cause mortality, cardiovascular death, and development of heart failure [2] Patients with DM2 have been noted to be at three to four times higher risk of mortality compared to the general population

These findings suggest that mitochondrial fragmentation and bioenergetic failure contribute to neurodegeneration and cognitive impairment in this model

however, this medication is not for everyone

Research has identified multiple pathways through which semaglutide impairs normal stomach function: Direct inhibition of gastric motility through vagus nerve modulation Disruption of gastric pacemaker cells that coordinate stomach contractions Impaired gastric accommodation in the fundus and body regions Antral hypomotility preventing proper food grinding and propulsion Dysregulation of pyloric sphincter relaxation blocking stomach emptying Alterations in small intestinal motility affecting the entire digestive process Clinical data reveals that up to 75% of patients with normal gastric emptying before receiving GLP-1 agonists developed delayed gastric emptying after treatment initiation, with some studies showing 30% experiencing severe delays qualifying as gastroparesis

T.KjaerM